These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31958081)

  • 1. Pine Bark Polyphenolic Extract Attenuates Amyloid-β and Tau Misfolding in a Model System of Alzheimer's Disease Neuropathology.
    Ono K; Zhao D; Wu Q; Simon J; Wang J; Radu A; Pasinetti GM
    J Alzheimers Dis; 2020; 73(4):1597-1606. PubMed ID: 31958081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
    Dal-Pan A; Dudonné S; Bourassa P; Bourdoulous M; Tremblay C; Desjardins Y; Calon F;
    J Alzheimers Dis; 2017; 55(1):115-135. PubMed ID: 27662290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease.
    Wang J; Ho L; Zhao W; Ono K; Rosensweig C; Chen L; Humala N; Teplow DB; Pasinetti GM
    J Neurosci; 2008 Jun; 28(25):6388-92. PubMed ID: 18562609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Amazon rain forest plant Uncaria tomentosa (cat's claw) and its specific proanthocyanidin constituents are potent inhibitors and reducers of both brain plaques and tangles.
    Snow AD; Castillo GM; Nguyen BP; Choi PY; Cummings JA; Cam J; Hu Q; Lake T; Pan W; Kastin AJ; Kirschner DA; Wood SG; Rockenstein E; Masliah E; Lorimer S; Tanzi RE; Larsen L
    Sci Rep; 2019 Feb; 9(1):561. PubMed ID: 30728442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment.
    Wang J; Ferruzzi MG; Ho L; Blount J; Janle EM; Gong B; Pan Y; Gowda GA; Raftery D; Arrieta-Cruz I; Sharma V; Cooper B; Lobo J; Simon JE; Zhang C; Cheng A; Qian X; Ono K; Teplow DB; Pavlides C; Dixon RA; Pasinetti GM
    J Neurosci; 2012 Apr; 32(15):5144-50. PubMed ID: 22496560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease.
    Ho L; Ferruzzi MG; Janle EM; Wang J; Gong B; Chen TY; Lobo J; Cooper B; Wu QL; Talcott ST; Percival SS; Simon JE; Pasinetti GM
    FASEB J; 2013 Feb; 27(2):769-81. PubMed ID: 23097297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel role of red wine-derived polyphenols in the prevention of Alzheimer's disease dementia and brain pathology: experimental approaches and clinical implications.
    Pasinetti GM
    Planta Med; 2012 Oct; 78(15):1614-9. PubMed ID: 23023952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.
    Oddo S; Caccamo A; Kitazawa M; Tseng BP; LaFerla FM
    Neurobiol Aging; 2003 Dec; 24(8):1063-70. PubMed ID: 14643377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.
    Ashrafian H; Zadeh EH; Khan RH
    Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation.
    Koller EJ; Ibanez KR; Vo Q; McFarland KN; Gonzalez De La Cruz E; Zobel L; Williams T; Xu G; Ryu D; Patel P; Giasson BI; Prokop S; Chakrabarty P
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12779. PubMed ID: 34825397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthocyanin suppresses the toxicity of Aβ deposits through diversion of molecular forms in in vitro and in vivo models of Alzheimer's disease.
    Yamakawa MY; Uchino K; Watanabe Y; Adachi T; Nakanishi M; Ichino H; Hongo K; Mizobata T; Kobayashi S; Nakashima K; Kawata Y
    Nutr Neurosci; 2016; 19(1):32-42. PubMed ID: 26304685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro comparison of major memory-support dietary supplements for their effectiveness in reduction/inhibition of beta-amyloid protein fibrils and tau protein tangles: key primary targets for memory loss.
    Snow AD; Cummings JA; Tanzi RE; Lake T
    Sci Rep; 2021 Feb; 11(1):3001. PubMed ID: 33589649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation.
    Luan K; Rosales JL; Lee KY
    Ageing Res Rev; 2013 Jan; 12(1):174-81. PubMed ID: 22728532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease.
    Pan K; Chen S; Wang Y; Yao W; Gao X
    Neuropharmacology; 2021 Sep; 196():108671. PubMed ID: 34153312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta plaque-bearing mice.
    Lam S; Hérard AS; Boluda S; Petit F; Eddarkaoui S; Cambon K; ; Picq JL; Buée L; Duyckaerts C; Haïk S; Dhenain M
    Acta Neuropathol Commun; 2022 Aug; 10(1):112. PubMed ID: 35974399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J; Schild A; Hoerndli F; Pennanen L
    Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.